Bioequivalence Study of Paracetamol With Oral Single Dose Administration in Healthy Adult Subjects Under Fasting Conditions

NCT06855576 PHASE1 COMPLETED

This study aims to evaluate the bioequivalence of new formulated orodispersible tablet (ODT) containing 500 milligram (mg) paracetamol in comparison to the European marketed Alvedon (paracetamol) 500 mg film-coated tablets and the Australian marketed Panadol (paracetamol) 500 mg film-coated tablets as reference products.

Details

Lead sponsor	HALEON
Phase	PHASE1
Status	COMPLETED
Enrolment	54
Start date	Wed Mar 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Apr 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Fever
• Pain

Interventions

• Paracetamol ODT
• Alvedon film-coated tablet
• Panadol film-coated Tablet

Countries

Germany